Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms... Show more
ICLR is expected to report earnings to rise 1.19% to $2.55 per share on July 29
Q2'26
Est.
$2.55
Q1'26
Missed
by $0.48
Q4'25
Missed
by $0.11
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.07
The last earnings report on May 27 showed earnings per share of $2.52, missing the estimate of $3.00. With 384.45K shares outstanding, the current market capitalization sits at 12.77B.